Neoimmunetech Inc DRC (950220)

Currency in KRW
539
-21(-3.75%)
Closed·
950220 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
526580
52 wk Range
5161,881
Key Statistics
Bid/Ask
539.00 / 541.00
Prev. Close
560
Open
560
Day's Range
526-580
52 wk Range
516-1,881
Volume
2.64M
Average Volume (3m)
4.67M
1-Year Change
-53.8527%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950220 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Neoimmunetech Inc DRC Company Profile

NeoImmuneTech, Inc., a clinical-stage T cell-based biotechnology company, develops and sells immuno-therapeutics in Korea. It is developing NT-I7, a clinical-stage more stable in the body, providing prolonged T cell amplification effects IL-7 for oncologic and infectious diseases; and Heterodimer hybrid Fc platform, an antibody platform technology, as well as NT2020, a T cell activator; NT3020, a T cell engager; NT4010, an advanced CAR-T; and NT5010, a TME modifier. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.

Compare 950220 to Peers and Sector

Metrics to compare
950220
Peers
Sector
Relationship
P/E Ratio
−1.9x−2.2x−0.5x
PEG Ratio
−0.020.010.00
Price/Book
0.8x1.9x2.6x
Price / LTM Sales
587.2x10.0x3.3x
Upside (Analyst Target)
-239.9%45.6%
Fair Value Upside
Unlock12.6%4.9%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 07, 2025
EPS / Forecast
-53.60 / --
Revenue / Forecast
18.33M / --
EPS Revisions
Last 90 days

950220 Income Statement

People Also Watch

140,600
042660
+8.32%
210,000
064350
+4.22%
463,000
079550
+0.65%
14,000
090710
0.00%
12,950
032820
+4.94%

FAQ

What Is the Neoimmunetech (950220) Stock Price Today?

The Neoimmunetech stock price today is 539 KRW.

What Stock Exchange Does Neoimmunetech Trade On?

Neoimmunetech is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Neoimmunetech?

The stock symbol for Neoimmunetech is "950220."

What Is the Neoimmunetech Market Cap?

As of today, Neoimmunetech market cap is 53.29B KRW.

What Is Neoimmunetech's Earnings Per Share (TTM)?

The Neoimmunetech EPS (TTM) is -93.

From a Technical Analysis Perspective, Is 950220 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Neoimmunetech Stock Split?

Neoimmunetech has split 0 times.

How Many Employees Does Neoimmunetech Have?

Neoimmunetech has 52 employees.

What is the current trading status of Neoimmunetech (950220)?

As of Feb 19, 2026, Neoimmunetech (950220) is trading at a price of 539 KRW, with a previous close of 560 KRW. The stock has fluctuated within a day range of 526 KRW to 580 KRW, while its 52-week range spans from 516 KRW to 1,881 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.